Skip to main content

Table 2 Human papillomavirus (HPV) by age and human immunodeficiency (HIV) status in women

From: Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status

  All women HIV-positive women HIV-negative women P-valuea
N = 484 N = 277 N = 207  
Any HPV
 All women 58.1 % (281/484) 74.0 % (205/277) 36.7 % (76/207) <0.0001
  18–25 years 74.1 % (63/85) 86.4 % (38/44) 61.0 % (25/41) 0.008
  26–35 years 59.0 % (111/188) 68.2 % (88/129) 39.0 % (23/59) 0.0002
  36–45 years 50.0 % (67/134) 73.2 % (52/71) 23.8 % (15/63) <0.0001
  46–66 years 51.9 % (40/77) 81.8 % (27/33) 29.5 % (13/44) <0.0001
Multiple HPV infections
 All women 34.3 % (166/484) 49.8 % (138/277) 13.5 % (28/207) <0.0001
  18–25 years 47.1 % (40/85) 61.4 % (27/44) 31.7 % (13/41) 0.007
  26–35 years 34.6 % (65/188) 45.0 % (58/129) 11.9 % (7/59) <0.0001
  36–45 years 30.6 % (41/134) 49.3 % (35/71) 9.5 % (6/63) <0.0001
  46–66 years 26.0 % (20/77) 54.5 % (18/33) 4.5 % (2/44) <0.0001
Single HPV infection
 All women 23.8 % (115/484) 24.2 % (67/277) 23.2 % (48/207) 0.800
  18–25 years 27.1 % (23/85) 25.0 % (11/44) 29.3 % (12/41) 0.664
  26–35 years 24.5 % (46/188) 23.3 % (30/129) 27.1 % (16/59) 0.570
  36–45 years 19.4 % (26/134) 23.9 % (17/71) 14.3 % (9/63) 0.161
  46–66 years 26.0 % (20/77) 27.3 % (9/33) 25.0 % (11/44) 0.828
HR-HPV
 All women 39.5 % (191/484) 52.0 % (144/277) 22.7 % (47/207) <0.0001
  18–25 years 54.1 % (46/85) 72.7 % (32/44) 34.1 % (14/41) 0.0004
  26–35 years 37.2 % (70/188) 40.3 % (52/129) 30.5 % (18/59) 0.199
  36–45 years 41.8 % (56/134) 64.8 % (46/71) 15.9 % (10/63) <0.0001
  46–66 years 24.7 % (19/77) 42.4 % (14/33) 11.4 % (5/44) 0.002
Probable HR-HPV
 All women 21.1 % (102/484) 30.7 % (85/277) 8.2 % (17/207) <0.0001
  18–25 years 25.9 % (22/85) 34.1 % (15/44) 17.1 % (7/41) 0.080
  26–35 years 27.1 % (51/188) 37.2 % (48/129) 5.1 % (3/59) <0.0001
  36–45 years 15.7 % (21/134) 22.5 % (16/71) 7.9 % (5/63) 0.02
  46–66 years 10.4 % (8/77) 18.2 % (6/33) 4.5 % (2/44) 0.055
LR-HPV
 All women 34.5 % (167/484) 49.8 % (138/277) 14.0 % (29/207) <0.0001
  18–25 years 44.7 % (38/85) 63.6 % (28/44) 24.4 % (10/41) 0.0003
  26–35 years 36.7 % (69/188) 48.1 % (62/129) 11.9 % (7/59) <0.0001
  36–45 years 26.9 % (36/134) 43.7 % (31/71) 7.9 % (5/63) <0.0001
  46–66 years 31.2 % (24/77) 51.5 % (17/33) 15.9 % (7/44) 0.0006
  1. Number of infection will not always add up because participants with multiple infection were sometimes counted more than once. acompares HIV-positive and HIV-negative women (chi-squared test)